[The action mechanisms of 12-0-tetradecanoylphorbol-13-acetate (TPA) and combined effects with TPA and fibroblast growth factor on the proliferation of leukemic myeloid progenitor cells].
Takahashi
T
T
Hirokawa
M
M
Kudo
K
K
Takatsu
H
H
Yoshida
K
K
Miura
A B
AB
D001854:Bone Marrow Cells; D002471:Cell Transformation, Neoplastic / Q000187:drug effects*; D002478:Cells, Cultured; D005346:Fibroblast Growth Factors / Q000494:pharmacology*; D006410:Hematopoiesis / Q000187:drug effects*; D006412:Hematopoietic Stem Cells / Q000473:pathology*; D006801:Humans; D007938:Leukemia / Q000097:blood*; D013755:Tetradecanoylphorbol Acetate / Q000031:analogs & derivatives* / Q000494:pharmacology
D005346:Fibroblast Growth Factors; C032975:12-O-tetradeca-2,4,6,8-tetranoylphorbol-13-acetate; D013755:Tetradecanoylphorbol Acetate